These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15202371)

  • 41. A historical view on the creation of the European society for cell and gene therapy.
    Cohen-Haguenauer O
    Hum Gene Ther; 2013 Jan; 24(1):4-11. PubMed ID: 23339284
    [No Abstract]   [Full Text] [Related]  

  • 42. Translational antiaging research.
    Swan M
    Rejuvenation Res; 2010 Feb; 13(1):115-7. PubMed ID: 20230285
    [No Abstract]   [Full Text] [Related]  

  • 43. 1983-2013: the long wave of biocatalysis.
    Riva S
    Trends Biotechnol; 2013 Mar; 31(3):120-1. PubMed ID: 23245656
    [No Abstract]   [Full Text] [Related]  

  • 44. Commentary on some recent theses relevant to combating aging: December 2012.
    Zealley B; de Grey AD
    Rejuvenation Res; 2012 Dec; 15(6):629-30. PubMed ID: 23327467
    [No Abstract]   [Full Text] [Related]  

  • 45. First gene therapy nears landmark European market authorization.
    Moran N
    Nat Biotechnol; 2012 Sep; 30(9):807-9. PubMed ID: 22965030
    [No Abstract]   [Full Text] [Related]  

  • 46. Triumph of the helix.
    Boyce N
    US News World Rep; 2003 Feb 24-Mar 3; 134(6):38-41, 45. PubMed ID: 12701251
    [No Abstract]   [Full Text] [Related]  

  • 47. Profile: Eduardo Kac.
    Herrera S
    Nat Biotechnol; 2005 Nov; 23(11):1331. PubMed ID: 16273048
    [No Abstract]   [Full Text] [Related]  

  • 48. Biotechnology industry roars into the millennium.
    Reh M
    J Natl Cancer Inst; 1998 Sep; 90(18):1324-6. PubMed ID: 9747860
    [No Abstract]   [Full Text] [Related]  

  • 49. Then and now.
    Verma I
    Nature; 2005 Jul; 436(7050):478-9. PubMed ID: 16049468
    [No Abstract]   [Full Text] [Related]  

  • 50. The unexpected outcomes of anti-aging, rejuvenation, and life extension studies: an origin of modern therapies.
    Stambler I
    Rejuvenation Res; 2014 Jun; 17(3):297-305. PubMed ID: 24524368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent progress and new challenges in metagenomics for biotechnology.
    Chistoserdova L
    Biotechnol Lett; 2010 Oct; 32(10):1351-9. PubMed ID: 20495950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mark Roth.
    Schmidt C
    Nat Biotechnol; 2009 Jan; 27(1):13. PubMed ID: 19131984
    [No Abstract]   [Full Text] [Related]  

  • 53. Introduction: gene therapy has gone from a pipe dream to clinical reality.
    Kordower JH; Kirik D
    Neurobiol Dis; 2012 Nov; 48(2):151-2. PubMed ID: 22841531
    [No Abstract]   [Full Text] [Related]  

  • 54. Baywatch: San Francisco.
    Smaglik P
    Nature; 2004 Feb; 427(6975):658-9. PubMed ID: 14961125
    [No Abstract]   [Full Text] [Related]  

  • 55. Emergence of a scientific and commercial research and development infrastructure for human gene therapy.
    Crofts C; Krimsky S
    Hum Gene Ther; 2005 Feb; 16(2):169-77. PubMed ID: 15761257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. When age becomes ageless.
    Greene J
    Hosp Health Netw; 1998 Jul; 72(13):18-20, 22, 24. PubMed ID: 9697607
    [No Abstract]   [Full Text] [Related]  

  • 57. Much ado about gene patents: the role of foreseeability.
    Gulliford MJ
    Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032
    [No Abstract]   [Full Text] [Related]  

  • 58. Leap of faith.
    Morgan R
    Mol Ther; 2014 Oct; 22(10):1717-8. PubMed ID: 25269938
    [No Abstract]   [Full Text] [Related]  

  • 59. Alois Jungbauer: protein bioengineering.
    Jungbauer A
    Biotechnol J; 2006 Jan; 1(1):26-7. PubMed ID: 16892219
    [No Abstract]   [Full Text] [Related]  

  • 60. Interview with James Heywood by Vicki Glaser.
    Heywood J
    Rejuvenation Res; 2011 Dec; 14(6):693-7. PubMed ID: 22175513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.